+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Respiratory Assist Devices Market - Global Forecast 2026-2032- Product Image
Respiratory Assist Devices Market - Global Forecast 2026-2032- Product Image
Sale

Respiratory Assist Devices Market - Global Forecast 2026-2032

  • Report

  • 192 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 6012367
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Respiratory Assist Devices Market is projected to reach USD 24.57 Billion in 2026. It is expected to continue growing at a CAGR of 7.06%, reaching USD 37.17 Billion by 2032.

Respiratory assist devices are central to modern respiratory care, spanning non-invasive ventilation, invasive ventilators, CPAP and BiPAP systems, oxygen concentrators, humidifiers, airway clearance systems, and connected monitoring accessories. Demand is anchored by a substantial disease burden: the World Health Organization identifies chronic obstructive pulmonary disease as a leading global cause of death, with 3.23 million deaths reported in 2019, while asthma, pneumonia, sleep-disordered breathing, and acute respiratory failure continue to increase the need for timely respiratory support.

The market is moving from hospital-centered critical care toward a broader continuum that includes emergency transport, long-term care, and home respiratory therapy. Aging populations, higher survival rates among patients with chronic cardiopulmonary disease, and the post-pandemic emphasis on oxygen availability, ventilator readiness, and non-invasive respiratory support are increasing procurement attention across health systems, payers, and homecare providers.

Transformative Shifts Reshaping Respiratory Care

The respiratory assist devices landscape is being reshaped by three structural shifts: care decentralization, device connectivity, and supply chain resilience. Hospitals continue to require advanced ventilators and high-flow oxygen support, but payers and clinicians are increasingly prioritizing home-based CPAP, BiPAP, portable oxygen concentrators, and remote monitoring to reduce avoidable readmissions and support chronic respiratory disease management.

Regulatory and procurement priorities are also changing. The COVID-19 response exposed vulnerabilities in oxygen infrastructure, ventilator availability, and component sourcing, prompting governments and providers to diversify suppliers, strengthen service networks, and validate device performance under emergency-use and routine-care conditions. Manufacturers that combine clinical reliability, interoperability, cybersecurity readiness, and lifecycle service support are best positioned for sustained adoption.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is increasingly influencing respiratory assist devices through smarter pressure titration, leak detection, predictive alarms, patient adherence analytics, and clinical decision support. In sleep therapy, algorithmic adjustment of airway pressure can improve comfort and adherence, while connected platforms help clinicians identify residual apnea events, mask fit issues, and therapy gaps without requiring frequent in-person visits.

In acute and critical care, AI-enabled analytics can support earlier detection of patient-ventilator asynchrony, deterioration risk, and weaning readiness. These applications do not replace clinical judgment, but they can reduce alarm fatigue, improve workflow efficiency, and enable more personalized respiratory support when validated with high-quality clinical data, cybersecurity controls, bias monitoring, and transparent performance governance.

Key Regional Insights for Respiratory Assist Devices

Asia-Pacific is a high-priority region for respiratory assist devices because of large patient populations, urban air pollution exposure, rising healthcare access, and expanding domestic manufacturing in China, India, Japan, South Korea, and Australia. The WHO has consistently linked air pollution exposure with respiratory and cardiovascular morbidity, reinforcing demand for oxygen therapy, non-invasive ventilation, and long-term respiratory care. North America remains a technology-intensive region, supported by established reimbursement pathways, high diagnostic awareness for obstructive sleep apnea, strong homecare networks, and sustained demand for connected respiratory monitoring.

Latin America is expanding through public hospital upgrades, private provider investment, and broader adoption of oxygen therapy in Brazil and Mexico, particularly for chronic respiratory disease and acute care readiness. Europe benefits from advanced clinical guidelines, a strong home respiratory care base, mature sleep medicine pathways, and procurement focus on energy efficiency, patient safety, and regulatory compliance. The Middle East is investing in tertiary care capacity, intensive care infrastructure, and medical tourism-linked specialty services, while Africa’s opportunity is closely tied to oxygen access, affordability, biomedical engineering capacity, local maintenance models, and reliable power supply for respiratory support systems.

Key Group Insights Across Economic and Policy Blocs

ASEAN markets are advancing through hospital modernization, growing private healthcare networks, urban pollution-related respiratory needs, and increasing demand for portable oxygen and non-invasive ventilation in major metropolitan centers. GCC countries are prioritizing advanced hospital infrastructure, intensive care capacity, premium homecare services, and digital health integration aligned with national healthcare transformation programs and broader investment in specialized care delivery.

The European Union emphasizes harmonized medical device regulation, clinical evidence, traceability, and post-market surveillance under the MDR framework, creating a premium for compliant and well-documented respiratory technologies. BRICS markets combine large respiratory disease burdens, air quality challenges, expanding healthcare access, and manufacturing ambitions, while the G7 leads in connected care adoption, reimbursement sophistication, clinical research capacity, and high-acuity respiratory innovation. NATO-aligned procurement considerations increasingly emphasize emergency preparedness, supply continuity, deployable respiratory support, and resilient medical logistics for crisis response.

Key Country Insights for Priority Markets

The United States leads in connected sleep therapy, home oxygen services, and advanced ICU ventilation, supported by strong clinical infrastructure, FDA oversight, established durable medical equipment channels, and high awareness of sleep-disordered breathing. Canada prioritizes equitable access, provincial procurement efficiency, and remote care delivery across dispersed populations, while Mexico and Brazil show rising demand through hospital expansion, private healthcare investment, and chronic respiratory disease management. In Europe, the United Kingdom, Germany, France, Italy, and Spain emphasize guideline-led respiratory care, home ventilation programs, sleep apnea treatment pathways, and compliance with EU or UK medical device requirements, while Russia maintains demand for critical care technologies and domestically supported supply chains.

China and India are scale markets shaped by large populations, air quality concerns, expanding hospital networks, and growing domestic production of oxygen and ventilation technologies. Japan and South Korea support high-quality respiratory care through aging-population needs, advanced electronics ecosystems, strong hospital capabilities, and established standards for device quality and patient safety. Australia combines mature reimbursement, rural and remote care challenges, and demand for reliable portable oxygen concentrators, CPAP systems, and non-invasive ventilation devices that support home-based respiratory therapy.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated connectivity, serviceability, and patient-centered design. Devices that reduce setup complexity, improve comfort, limit noise, enhance portability, and provide actionable adherence or ventilation data can strengthen outcomes for providers and homecare organizations while supporting payer expectations for measurable value.

Manufacturers should also diversify component sourcing, invest in regional service hubs, strengthen biomedical engineering training, and align product portfolios with local oxygen infrastructure realities. Strategic partnerships with hospitals, sleep labs, distributors, emergency preparedness agencies, and digital health platforms can accelerate adoption, but success will depend on cybersecurity, regulatory readiness, transparent AI validation, usability testing, and robust post-market surveillance.

Research Methodology

This executive summary is developed through a structured secondary and primary research approach aligned with evidence-based market intelligence practices. Secondary inputs include public health data from recognized authorities such as the WHO, CDC, FDA, EMA, national health agencies, peer-reviewed literature, medical device regulations, clinical guidelines, reimbursement references, adverse event databases, and publicly available industry disclosures.

Primary validation typically incorporates expert interviews across manufacturers, distributors, clinicians, respiratory therapists, biomedical engineers, procurement leaders, and homecare service providers. Findings are triangulated across disease burden, technology adoption, regulatory pathways, installed base indicators, supply chain signals, clinical use cases, and regional healthcare investment to produce evidence-led interpretation without relying on market sizing, market share, or forecasting.

Conclusion

The respiratory assist devices market is entering a more connected, resilient, and patient-centric phase. Adoption is supported by chronic respiratory disease prevalence, aging demographics, sleep apnea diagnosis, emergency preparedness, oxygen infrastructure investment, and the expansion of home-based respiratory care.

Competitive advantage will increasingly depend on validated clinical performance, reliable supply, digital interoperability, AI governance, cybersecurity, usability, and strong service infrastructure. Companies that combine high-acuity innovation with affordable, scalable respiratory support solutions will be best positioned to meet global healthcare needs across hospitals, emergency settings, long-term care, and home therapy environments.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Respiratory Assist Devices Market, by Offering
7.1. Introduction
7.2. Positive Airway Pressure (PAP) Devices
7.2.1. Continuous Positive Airway Pressure (CPAP) Devices
7.2.2. Automatic Positive Airway Pressure (APAP) Devices
7.2.3. Bilevel Positive Airway Pressure (BiPAP) Devices
7.3. Ventilators
7.4. Mask & Interfaces
7.4.1. Nasal Masks
7.4.2. Full Face Masks
7.5. Resuscitation Devices
7.6. Airway Clearance Assist Devices
7.7. Solutions
7.7.1. Remote Monitoring
7.7.2. Data Management
7.8. Services
7.8.1. Maintenance & Support
7.8.2. Calibration
8. Respiratory Assist Devices Market, by Device Type
8.1. Introduction
8.2. Stationary
8.3. Tabletop
8.4. Portable
9. Respiratory Assist Devices Market, by Patient Interface
9.1. Introduction
9.2. Nasal Interfaces
9.3. Oral Interfaces
9.4. Invasive Airway Interfaces
9.4.1. Endotracheal Tube
9.4.2. Tracheostomy Tube
10. Respiratory Assist Devices Market, by Application
10.1. Introduction
10.2. Chronic Obstructive Pulmonary Disease (COPD)
10.3. Emergency & Trauma Care
10.4. Sleep Apnea Therapy
10.4.1. Central Sleep Apnea
10.4.2. Obstructive Sleep Apnea
10.5. Respiratory Failure
10.5.1. Acute
10.5.2. Chronic
10.6. Neonatal Respiratory Disorders
11. Respiratory Assist Devices Market, by Care Setting
11.1. Introduction
11.2. Hospitals
11.3. Specialty Clinics
11.4. Home Healthcare
11.5. Ambulatory Care Centers
12. Respiratory Assist Devices Market, by Patient Age Group
12.1. Introduction
12.2. Pediatric
12.3. Adult
12.4. Geriatric
12.5. Neonatal
12.6. Infant
13. Respiratory Assist Devices Market, by Distribution Channel
13.1. Introduction
13.2. Offline Sales
13.3. Online Sales
13.3.1. Manufacturer Websites
13.3.2. eCommerce Platforms
14. Respiratory Assist Devices Market, by Region
14.1. North America
14.2. Europe
14.3. Asia-Pacific
14.4. Latin America
14.5. Africa
14.6. Middle East
15. Respiratory Assist Devices Market, by Group
15.1. NATO
15.2. G7
15.3. European Union
15.4. BRICS
15.5. ASEAN
15.6. GCC
16. Respiratory Assist Devices Market, by Country
16.1. United States
16.2. China
16.3. Canada
16.4. Germany
16.5. Brazil
16.6. Mexico
16.7. Japan
16.8. India
16.9. United Kingdom
16.10. France
16.11. Italy
16.12. Australia
16.13. South Korea
16.14. Russia
16.15. Spain
17. Competitive Landscape
17.1. Market Share Analysis, 2025
17.2. FPNV Positioning Matrix, 2025
17.3. Market Concentration Analysis, 2025
17.3.1. Concentration Ratio (CR)
17.3.2. Herfindahl Hirschman Index (HHI)
17.4. Recent Developments & Impact Analysis, 2025
17.5. Product Portfolio Analysis, 2025
17.6. Benchmarking Analysis, 2025
18. Company Profiles
18.1. ResMed Inc.
18.2. Fisher & Paykel Healthcare Limited
18.3. Koninklijke Philips N.V.
18.4. Getinge AB
18.5. Drägerwerk AG & Co. KGaA
18.6. GE HealthCare Technologies Inc.
18.7. Medtronic plc
18.8. Hamilton Medical AG
18.9. SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
18.10. Inogen Inc.
18.11. Baxter International Inc.
18.12. Drive DeVilbiss Healthcare Ltd.
18.13. PARI GmbH
18.14. Löwenstein Medical SE & Co. KG
18.15. React Health
18.16. AdaptHealth, LLC
18.17. Air Liquide S.A.
18.18. AirLife
18.19. Apex Medical Devices
18.20. BMC Medical Co. Ltd.
18.21. Breas Medical AB
18.22. Cardinal Health, Inc.
18.23. Masimo Corporation
18.24. Medline Industries, LP
18.25. Natus Medical Incorporated
18.26. Nihon Kohden Corporation
18.27. OMRON Healthcare, Inc.
18.28. Schiller AG
18.29. Shenyang Canta Medical Tech Co., Ltd.
18.30. Smiths Group plc
18.31. TE Connectivity plc
18.32. Teijin Limited
18.33. Teleflex Incorporated
18.34. ZOLL Medical Corporation
List of Figures
FIGURE 1. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2025 VS 2032 (%)
FIGURE 7. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2032 (%)
FIGURE 9. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2025 VS 2032 (%)
FIGURE 11. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2025 VS 2032 (%)
FIGURE 15. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 19. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 21. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 23. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 25. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 26. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 27. GLOBAL RESPIRATORY ASSIST DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL CONTINUOUS POSITIVE AIRWAY PRESSURE (CPAP) DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL AUTOMATIC POSITIVE AIRWAY PRESSURE (APAP) DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL BILEVEL POSITIVE AIRWAY PRESSURE (BIPAP) DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL VENTILATORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL VENTILATORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL VENTILATORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL MASK & INTERFACES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL MASK & INTERFACES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL MASK & INTERFACES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL NASAL MASKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL NASAL MASKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL NASAL MASKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL FULL FACE MASKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL FULL FACE MASKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL FULL FACE MASKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL RESUSCITATION DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL AIRWAY CLEARANCE ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL REMOTE MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL REMOTE MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL REMOTE MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL DATA MANAGEMENT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL DATA MANAGEMENT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL DATA MANAGEMENT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL MAINTENANCE & SUPPORT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL CALIBRATION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL CALIBRATION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL CALIBRATION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TABLETOP MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TABLETOP MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL TABLETOP MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL NASAL INTERFACES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL NASAL INTERFACES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL NASAL INTERFACES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL ORAL INTERFACES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL ORAL INTERFACES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL ORAL INTERFACES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL INVASIVE AIRWAY INTERFACES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL ENDOTRACHEAL TUBE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL TRACHEOSTOMY TUBE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL EMERGENCY & TRAUMA CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL SLEEP APNEA THERAPY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CENTRAL SLEEP APNEA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL OBSTRUCTIVE SLEEP APNEA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL RESPIRATORY FAILURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL ACUTE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL ACUTE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL ACUTE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CHRONIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CHRONIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL CHRONIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL NEONATAL RESPIRATORY DISORDERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL HOME HEALTHCARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL HOME HEALTHCARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL HOME HEALTHCARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL INFANT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL INFANT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL INFANT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL OFFLINE SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL OFFLINE SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL OFFLINE SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL ONLINE SALES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL ONLINE SALES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL ONLINE SALES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL MANUFACTURER WEBSITES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL ECOMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 158. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 159. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 160. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 161. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 162. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 163. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 164. NORTH AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 165. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 166. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 167. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 168. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 169. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 170. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 171. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 172. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 173. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 174. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 175. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 176. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 177. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 178. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 179. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 180. EUROPE RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 192. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 193. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 194. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 195. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 196. ASIA-PACIFIC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 197. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 198. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 199. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 200. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 201. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 202. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 203. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 204. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 205. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 206. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 207. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 208. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 209. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 210. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 211. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 212. LATIN AMERICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 213. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 214. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 215. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 216. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 217. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 218. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 219. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 220. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 221. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 222. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 223. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 224. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 225. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 226. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 227. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 228. AFRICA RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 229. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 230. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 231. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 232. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 233. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 234. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 235. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 236. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 237. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 238. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 239. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 240. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 241. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 242. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 243. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 244. MIDDLE EAST RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 245. GLOBAL RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 246. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 247. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 248. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 249. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 250. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 251. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 252. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 253. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 254. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 255. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 256. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 257. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 258. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 259. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 260. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 261. NATO RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 262. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 263. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 264. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 265. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 266. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 267. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 268. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 269. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 270. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 271. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 272. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 273. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 274. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 275. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 276. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 277. G7 RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 278. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 279. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 280. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 281. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 282. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 283. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 284. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 285. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 286. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 287. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 288. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 289. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 290. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 291. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 292. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 293. EUROPEAN UNION RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 294. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 295. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 296. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 297. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 298. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 299. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 300. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 301. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 302. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 303. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 304. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 305. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 306. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 307. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 308. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. BRICS RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 310. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 311. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 312. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 313. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 314. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 315. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 316. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 317. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 318. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 319. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 320. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 321. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 322. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 323. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 324. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 325. ASEAN RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLION)
TABLE 326. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 327. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY OFFERING, 2017-2032 (USD MILLION)
TABLE 328. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY POSITIVE AIRWAY PRESSURE (PAP) DEVICES, 2017-2032 (USD MILLION)
TABLE 329. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY MASK & INTERFACES, 2017-2032 (USD MILLION)
TABLE 330. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 331. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SERVICES, 2017-2032 (USD MILLION)
TABLE 332. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DEVICE TYPE, 2017-2032 (USD MILLION)
TABLE 333. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT INTERFACE, 2017-2032 (USD MILLION)
TABLE 334. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY INVASIVE AIRWAY INTERFACES, 2017-2032 (USD MILLION)
TABLE 335. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 336. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY SLEEP APNEA THERAPY, 2017-2032 (USD MILLION)
TABLE 337. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY RESPIRATORY FAILURE, 2017-2032 (USD MILLION)
TABLE 338. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY CARE SETTING, 2017-2032 (USD MILLION)
TABLE 339. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2017-2032 (USD MILLION)
TABLE 340. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 341. GCC RESPIRATORY ASSIST DEVICES MARKET SIZE, BY ONLINE SALES, 2017-2032 (USD MILLIO

Companies Mentioned

  • ResMed Inc.
  • Fisher & Paykel Healthcare Limited
  • Koninklijke Philips N.V.
  • Getinge AB
  • Drägerwerk AG & Co. KGaA
  • GE HealthCare Technologies Inc.
  • Medtronic plc
  • Hamilton Medical AG
  • SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
  • Inogen Inc.
  • Baxter International Inc.
  • Drive DeVilbiss Healthcare Ltd.
  • PARI GmbH
  • Löwenstein Medical SE & Co. KG
  • React Health
  • AdaptHealth, LLC
  • Air Liquide S.A.
  • AirLife
  • Apex Medical Devices
  • BMC Medical Co. Ltd.
  • Breas Medical AB
  • Cardinal Health, Inc.
  • Masimo Corporation
  • Medline Industries, LP
  • Natus Medical Incorporated
  • Nihon Kohden Corporation
  • OMRON Healthcare, Inc.
  • Schiller AG
  • Shenyang Canta Medical Tech Co., Ltd.
  • Smiths Group plc
  • TE Connectivity plc
  • Teijin Limited
  • Teleflex Incorporated
  • ZOLL Medical Corporation

Table Information

Report AttributeDetails
No. of Pages192
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 24.57 Billion
Forecasted Market Value ( USD ) by 2032 $ 37.17 Billion
Compound Annual Growth Rate7.0%
Regions CoveredGlobal
No. of Companies Mentioned34

Related Topics

Related Reports

Therapeutic Respiratory Devices Market - Global Forecast 2026-2032 - Product Image

Therapeutic Respiratory Devices Market - Global Forecast 2026-2032

  • Report
  • 184 Pages
  • Global
From
Respiratory Care Devices Market - Global Forecast 2026-2032 - Product Image

Respiratory Care Devices Market - Global Forecast 2026-2032

  • Report
  • 186 Pages
  • Global
From
Cough Assist Devices - Global Strategic Business Report - Product Image

Cough Assist Devices - Global Strategic Business Report

  • Report
  • 372 Pages
  • Global
From
Therapeutic Respiratory Devices - Global Strategic Business Report - Product Image

Therapeutic Respiratory Devices - Global Strategic Business Report

  • Report
  • 285 Pages
  • Global
From
Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032 - Product Image

Sleep Apnea Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032

  • Report
  • 150 Pages
  • Global
From

About the Respiratory Assist Device Market

The Respiratory Assist Device (RAD) market is a subset of the larger Respiratory Devices market. RADs are used to provide respiratory support to patients with breathing difficulties, such as those with chronic obstructive pulmonary disease (COPD) or acute respiratory distress syndrome (ARDS). These devices are designed to provide mechanical ventilation, oxygen therapy, and other forms of respiratory support. RADs are typically used in hospitals, but can also be used in home care settings. RADs are typically classified into two categories: invasive and non-invasive. Invasive RADs are inserted directly into the patient's airway, while non-invasive RADs are placed over the patient's nose and mouth. Both types of RADs are used to provide respiratory support, but the type of device used depends on the patient's condition and the severity of their breathing difficulties. The RAD market is highly competitive, with a number of companies offering a variety of devices. Some of the major players in the market include Philips Respironics, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.